Legochem Biosciences Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Legochem Biosciences Inc with three other
companies in this sector in South Korea:
sales of 24.08 billion Korean Won [US$20.03 million]
of which 100%
was Biotechnology business),
(25.80 billion Korean Won [US$21.46 million]
of which 54%
was Diagnosis), and
Dna Link Inc
(14.88 billion Korean Won [US$12.38 million]
During the year ended December of 2018, sales at
Legochem Biosciences Inc were 25.24 billion Korean Won (US$21.00 million).
increase of 14.4%
versus 2017, when the company's sales were 22.06 billion Korean Won.
This was the fifth consecutive year of sales increases at Legochem Biosciences Inc
(and since 2013, sales have increased a total of 2,905%).
Sales of Medical Development saw an increase
20.9% in 2018, from
18.81 billion Korean Won to 22.75 billion Korean Won.
Not all segments of Legochem Biosciences Inc experienced an increase in sales in 2018:
sales of New Drugs R and D fell 23.2% to 2.49 billion Korean Won.